Mark E. Zupec

663 total citations
18 papers, 546 citations indexed

About

Mark E. Zupec is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Mark E. Zupec has authored 18 papers receiving a total of 546 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Mark E. Zupec's work include Peptidase Inhibition and Analysis (6 papers), Chemical Synthesis and Analysis (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Mark E. Zupec is often cited by papers focused on Peptidase Inhibition and Analysis (6 papers), Chemical Synthesis and Analysis (4 papers) and Carbohydrate Chemistry and Synthesis (4 papers). Mark E. Zupec collaborates with scholars based in United States and United Kingdom. Mark E. Zupec's co-authors include Sandra K. Freeman, James A. Sikorski, Balekudru Devadas, Daniel P. Getman, Charles A. McWherter, Jeffrey I. Gordon, Srinivasan Nagarajan, David Brown, Nandini S. Kishore and F. S. TJOENG and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Mark E. Zupec

18 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark E. Zupec United States 15 326 115 91 73 61 18 546
Robert L. Tansik United States 13 385 1.2× 220 1.9× 87 1.0× 38 0.5× 85 1.4× 19 849
Jeffrey A. Loy United States 11 408 1.3× 62 0.5× 129 1.4× 37 0.5× 86 1.4× 12 821
Geraint L. Francis United Kingdom 8 508 1.6× 108 0.9× 66 0.7× 80 1.1× 50 0.8× 11 734
Geoffrey Allen United Kingdom 11 385 1.2× 43 0.4× 99 1.1× 28 0.4× 23 0.4× 15 592
G A Orr United States 16 498 1.5× 99 0.9× 229 2.5× 26 0.4× 40 0.7× 23 882
Paulo Boschcov Brazil 12 253 0.8× 55 0.5× 105 1.2× 21 0.3× 8 0.1× 23 533
David G. Osterman United States 13 510 1.6× 61 0.5× 48 0.5× 26 0.4× 35 0.6× 16 672
Y. Yosaatmadja New Zealand 16 525 1.6× 97 0.8× 132 1.5× 44 0.6× 137 2.2× 20 791
Anthony W. Yem United States 16 792 2.4× 50 0.4× 182 2.0× 82 1.1× 44 0.7× 30 991
Jörg Kallen Switzerland 12 738 2.3× 156 1.4× 183 2.0× 64 0.9× 24 0.4× 17 870

Countries citing papers authored by Mark E. Zupec

Since Specialization
Citations

This map shows the geographic impact of Mark E. Zupec's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Zupec with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Zupec more than expected).

Fields of papers citing papers by Mark E. Zupec

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Zupec. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Zupec. The network helps show where Mark E. Zupec may publish in the future.

Co-authorship network of co-authors of Mark E. Zupec

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Zupec. A scholar is included among the top collaborators of Mark E. Zupec based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Zupec. Mark E. Zupec is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Webber, R. Keith, William M. Moore, Jane R. Connor, et al.. (1998). Substituted 2-Iminopiperidines as Inhibitors of Human Nitric Oxide Synthase Isoforms. Journal of Medicinal Chemistry. 41(1). 96–101. 38 indexed citations
2.
McWherter, Charles A., Warren J. Rocque, Mark E. Zupec, et al.. (1997). Scanning Alanine Mutagenesis and De-peptidization of a Candida albicans Myristoyl-CoA:ProteinN-Myristoyltransferase Octapeptide Substrate Reveals Three Elements Critical for Molecular Recognition. Journal of Biological Chemistry. 272(18). 11874–11880. 29 indexed citations
3.
Sikorski, James A., Balekudru Devadas, Mark E. Zupec, et al.. (1997). Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: Protein N-myristoyltransferase: A new approach to antifungal therapy. Biopolymers. 43(1). 43–71. 46 indexed citations
4.
5.
Nagarajan, Srinivasan, Balekudru Devadas, Mark E. Zupec, et al.. (1997). Conformationally Constrained [p-(ω-Aminoalkyl)phenacetyl]-l-seryl-l-lysyl Dipeptide Amides as Potent Peptidomimetic Inhibitors of Candida albicans and Human Myristoyl-CoA:Protein N-Myristoyl Transferase. Journal of Medicinal Chemistry. 40(10). 1422–1438. 40 indexed citations
6.
Brown, David, Balekudru Devadas, Srinivasan Nagarajan, et al.. (1997). Replacements for lysine in l-seryl-l-lysyl dipeptide amide inhibitors of candida albicans myristoyl-CoA:protein N-myristoyltransferase. Bioorganic & Medicinal Chemistry Letters. 7(3). 379–382. 10 indexed citations
7.
Lodge, Jennifer K., Emily Jackson-Machelski, Balekudru Devadas, et al.. (1997). N-Myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA:protein N-myristoyltransferase. Microbiology. 143(2). 357–366. 37 indexed citations
8.
Zablocki, Jeffery A., Foe S. Tjoeng, Philippe R. Bovy, et al.. (1995). A novel series of orally active antiplatelet agents. Bioorganic & Medicinal Chemistry. 3(5). 539–551. 30 indexed citations
9.
Devadas, Balekudru, Mark E. Zupec, Sandra K. Freeman, et al.. (1995). Design and Syntheses of Potent and Selective Dipeptide Inhibitors of Candida albicans Myristoyl-CoA:Protein N-Myristoyltransferase. Journal of Medicinal Chemistry. 38(11). 1837–1840. 53 indexed citations
10.
Bovy, Philippe R., F. S. TJOENG, Thomas E. Rogers, et al.. (1994). Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents. Bioorganic & Medicinal Chemistry. 2(9). 881–895. 10 indexed citations
11.
Nicholson, Nancy S., Susan G. Panzer‐Knodle, Anita K. Salyers, et al.. (1991). In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent. Thrombosis Research. 62(5). 567–578. 38 indexed citations
12.
Byatt, John C., et al.. (1990). Isolation of Genomic Sequence Encoding a Biologically Active Bovine TGF- α Protein. Growth Factors. 3(4). 257–266. 23 indexed citations
13.
Zupec, Mark E., et al.. (1990). Chemical synthesis of bovine transforming growth factor-α: Synthesis, characterization and biological activity. Biochemical and Biophysical Research Communications. 167(2). 484–491. 16 indexed citations
14.
Green, David W., Serdar Aykent, James K. Gierse, & Mark E. Zupec. (1990). Substrate specificity of recombinant human renal renin: effect of histidine in the P2 subsite of pH dependence. Biochemistry. 29(12). 3126–3133. 33 indexed citations
15.
Nicholson, Nancy S., Susan G. Panzer‐Knodle, Anita K. Salyers, et al.. (1990). Antiplatelet and antithrombotic effects of platelet glycoprotein IIb/IIIa (GPIIb/IIIa) inhibition by arginine-glycine-aspartic acid-serine (RGDS) and arginine-glycine-aspartic acid (RGD) (O-me)Y (SC-46749).. Journal of Pharmacology and Experimental Therapeutics. 256(3). 876–882. 17 indexed citations
16.
Tjoeng, Foe S., et al.. (1990). Multiple peptide synthesis using a single support (MPS3). International journal of peptide & protein research. 35(2). 141–146. 31 indexed citations
17.
Olins, Gillian M., Pramod P. Mehta, Delores J. Blehm, et al.. (1987). Phosphorylation of high‐ and low‐molecular‐mass atrial natriuretic peptide analogs by cyclic AMP‐dependent protein kinase. FEBS Letters. 224(2). 325–330. 13 indexed citations
18.
Katsube, Nobuo, K. Wakitani, Kam F. Fok, et al.. (1985). Differential structure-activity relationships of atrial peptides as natriuretics and renal vasodilators in the dog. Biochemical and Biophysical Research Communications. 128(1). 325–330. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert L. Tansik Breakdown of academic impact, for papers by Jeffrey A. Loy Breakdown of academic impact, for papers by Geraint L. Francis Breakdown of academic impact, for papers by Geoffrey Allen Breakdown of academic impact, for papers by G A Orr Breakdown of academic impact, for papers by Paulo Boschcov Breakdown of academic impact, for papers by David G. Osterman Breakdown of academic impact, for papers by Y. Yosaatmadja Breakdown of academic impact, for papers by Anthony W. Yem Breakdown of academic impact, for papers by Jörg Kallen
Rankless by CCL
2026